================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 21, 2003
Kewaunee Scientific Corporation
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-5286 38-0715562
---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
2700 West Front Street
Statesville, North Carolina 28677
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 704-873-7202
N/A
------------------------------------------------------------
(Former name or former address if changed since last report)
================================================================================
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Subject Matter
99.1 Press Release dated November 21, 2003, of Kewaunee Scientific
Corporation, announcing its second quarter earnings.
Item 12. Results of Operations and Financial Condition.
On November 21, 2003 Kewaunee Scientific Corporation (the
"Company") issued a Press Release announcing its second
quarter earnings. The Press Release is incorporated herein by
reference, and is included as Exhibit 99.1 to this Current
Report on Form 8-K.
Exhibit 99.1 to this report contains information regarding
certain non-recurring charges incurred by the Company. For
comparative purposes, following the disclosure of certain
financial measures in Exhibit 99.1 which include the
applicable non-recurring charges, such additional information
constituting a "non-GAAP financial measure" as defined in Item
10 of Regulation S-K of the Securities Exchange Act of 1934,
as amended The Company has included this additional
information because it believes that the disclosure of such
information which excludes the non-recurring charges is a
better measure of the Company's performance during the periods
reported and is more useful for comparing the Company's
results of operations to prior periods.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
(Registrant)
Kewaunee Scientific Corporation
Date: November 21, 2003 By: /s/ D. Michael Parker
-------------------------------
Senior Vice President, Finance
Chief Financial Officer
3